Atlas Trials

Stage IV Adenoid Cystic Carcinoma of the Oral Cavity

13 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Stage IV Adenoid Cystic Carcinoma of the Oral Cavity

RecordFirmDate
Transoral Robotic Surgery in Treating Patients With Benign or Stage I-IV Head and Neck Cancer (NCT01254734)City of Hope Medical Center2011-04-01
Esophagoscopy in Evaluating Treatment in Patients With Stage I-IV Head and Neck Cancer Who Are Undergoing Radiation Therapy and/or Chemotherapy (NCT01164566)Wake Forest University Health Sciences2010-12-01
L-lysine in Treating Oral Mucositis in Patients Undergoing Radiation Therapy With or Without Chemotherapy For Head and Neck Cancer (NCT01155609)University of Washington2010-09-01
Cetuximab and Everolimus in Treating Patients With Metastatic or Recurrent Colon Cancer or Head and Neck Cancer (NCT01637194)Fox Chase Cancer Center2008-11-01
Bevacizumab in Reducing CNS Side Effects in Patients Who Have Undergone Radiation Therapy to the Brain for Primary Brain Tumor, Meningioma, or Head and Neck Cancer (NCT00492089)National Cancer Institute (NCI)2007-06-01
Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer (NCT00397384)National Cancer Institute (NCI)2007-01-01
Erlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung Cancer (NCT00101348)National Cancer Institute (NCI)2005-01-01
Alvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors (NCT00089362)National Cancer Institute (NCI)2004-07-01
Bortezomib Followed by the Addition of Doxorubicin at Disease Progression in Treating Patients With Locally Advanced, Recurrent, or Metastatic Adenoid Cystic Carcinoma (Cancer) of the Head and Neck (NCT00077428)National Cancer Institute (NCI)2004-06-01
7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007) (NCT00031681)National Cancer Institute (NCI)2001-12-01
Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction (NCT00030498)National Cancer Institute (NCI)2001-12-01
Bevacizumab, Fluorouracil, and Hydroxyurea Plus Radiation Therapy in Treating Patients With Advanced Head and Neck Cancer (NCT00023959)National Cancer Institute (NCI)2001-07-01
Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu (NCT00004074)National Cancer Institute (NCI)1999-08-01

Track Stage IV Adenoid Cystic Carcinoma of the Oral Cavity automatically

Every clearance here is in the API, with alerts when new ones post.